RLMD Relmada Therapeutics, Inc. - Common Stock
$7,08
Prix · Mai 20, 2026
Données fondamentales au Mai 12, 2026
Fourchette 52 semaines
$0–$8
88% of range
Note des analystes
BUY
11 analysts
Objectif de cours
$13
+81% upside
P/E (TTM)
-3.3
ROE
-112.0%
Marge nette
—
RLMD Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
Prix
$7.08
Capitalisation Boursière
$354M
P/E (TTM)
-3.3
BPA (TTM)
$-1.45
Revenus (TTM)
—
Rendement div.
—
ROE
-112.0%
Dette/Capitaux propres
—
Fourchette 52 semaines
$0 – $8
RLMD Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
Configure
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Revenus et bénéfice net
—
BPA
$-1.45
2021-12-31
→
2025-12-31
Flux de trésorerie libre
—
2018-06-30
→
2020-12-31
Marges
—
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
Métrique
Tendance sur 5 ans
RLMD
Médiane des pairs
P/E (TTM)
-3.3
42.1
P/S (TTM)
64260.0
11.8
P/B
4.1
3.4
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
Métrique
Tendance sur 5 ans
RLMD
Médiane des pairs
ROA
-82.1%
-5.4%
ROE
-112.0%
-23.4%
Santé financière Dette, liquidité, solvabilité — solidité du bilan
Métrique
Tendance sur 5 ans
RLMD
Médiane des pairs
Current Ratio (Ratio de liquidité)
14.6
4.0
Quick Ratio (Ratio de liquidité réduite)
14.5
—
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
Métrique
Tendance sur 5 ans
RLMD
Médiane des pairs
Revenue YoY (Chiffre d'affaires YoY)
93.7%
—
Revenue CAGR 3Y (CAGR du chiffre d'affaires 3 ans)
54.4%
—
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
Métrique
Tendance sur 5 ans
RLMD
Médiane des pairs
RLMD Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
ACHAT
11 analystes
- Achat fort 4 36,4%
- Achat 6 54,5%
- Conserver 1 9,1%
- Vente 0 0,0%
- Vente forte 0 0,0%
Objectif de cours à 12 mois
5 analystes · 2026-05-19
Médiane
$12.00
Moyenne
$12.80
← En dessous de tous les objectifs
$7.08
Bas
$9.00
Haut
$19.00
Objectif médian
$12.00
+69,5%
Objectif moyen
$12.80
+80,8%
Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
Surprise Moyenne
-0.09%
| Période | EPS Actual | BPA est. | Surprise |
|---|---|---|---|
| 31 mars 2026 | $-0.22 | $-0.20 | -0.02% |
| 31 décembre 2025 | $-0.29 | $-0.14 | -0.15% |
| 30 septembre 2025 | $-0.30 | $-0.12 | -0.18% |
| 30 juin 2025 | $-0.30 | $-0.26 | -0.04% |
| 31 mars 2025 | $-0.58 | $-0.32 | -0.26% |
| 31 décembre 2024 | $-0.62 | $-0.71 | 0.09% |
Comparaison avec les pairs Indicateurs clés par rapport aux pairs du secteur
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| RLMD | $354M | -3.3 | 93.7% | — | -112.0% | — |
| ESPR | — | -33.6 | 21.3% | -5.6% | 6.2% | — |
| AMPH | $1.22B | 13.2 | -1.7% | 13.6% | 12.7% | 49.5% |
| LBRX | $563M | -7.1 | — | — | -25.5% | — |
| SGP | — | — | — | — | 50.0% | — |
| BIOA | $495M | -5.9 | — | -896.1% | -28.4% | — |
| ANRO | $568M | -8.1 | — | — | -46.1% | — |
| ACRS | $363M | -5.7 | -58.2% | -829.6% | -55.3% | — |
| CRMD | $922M | 5.7 | 617.0% | 52.3% | 52.1% | 88.5% |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat 12
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $27M | $46M | $55M | $113M | $91M | $36M | $8M | $7M | $3M | $1M | · | · | |
| SG&A Expense | $32M | $38M | $49M | $48M | $35M | $25M | $7M | $6M | $4M | $6M | · | · | |
| Operating Expenses | $59M | $84M | $104M | $161M | $126M | $61M | $15M | $13M | $7M | $7M | · | · | |
| Operating Income | $-59M | $-84M | $-104M | $-161M | $-126M | $-61M | $-15M | $-13M | $-7M | $-7M | · | · | |
| Interest Income | $1M | $4M | $5M | · | · | · | · | · | · | · | · | · | |
| Other Non-op | $2M | $4M | $5M | $4M | $-48.3K | $1M | $104.1K | $-5M | $-2M | $932.3K | · | · | |
| Net Income | $-57M | $-80M | $-99M | $-157M | $-126M | $-59M | $-15M | $-17M | $-9M | $-6M | · | · | |
| EPS (Basic) | $-1.45 | $-2.65 | $-3.28 | $-5.30 | $-7.16 | · | · | · | · | · | · | · | |
| EPS (Diluted) | $-1.45 | $-2.65 | $-3.28 | $-5.30 | $-7.16 | · | · | · | · | · | · | · | |
| Shares (Basic) | 39,479,694 | 30,163,751 | 30,099,203 | 29,628,664 | 17,552,738 | · | · | · | · | · | · | · | |
| Shares (Diluted) | 39,479,694 | 30,163,751 | 30,099,203 | 29,628,664 | 17,552,738 | · | · | · | · | · | · | · | |
| EBITDA | $-59M | $-84M | $-104M | $-161M | $-126M | $-61M | · | $-13M | $-7M | · | · | · |
Bilan 22
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $3M | $4M | $4M | $5M | $44M | $2M | $36M | $9M | $2M | $2M | $9M | · | |
| Short-term Investments | $90M | $41M | $92M | $143M | $167M | $115M | $80M | · | · | · | · | · | |
| Receivables | · | · | · | $512.4K | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $977.7K | $886.5K | $1M | $4M | $11M | $903.2K | $423.9K | $520.7K | $426.9K | $472.5K | · | · | |
| Current Assets | $94M | $46M | $98M | $153M | $223M | $118M | $117M | $10M | $3M | $2M | · | · | |
| PP&E (Net) | · | · | · | · | · | $1.3K | $5.0K | $7.2K | $12.1K | $2.3K | · | · | |
| PP&E (Gross) | · | · | · | · | $16.7K | $16.7K | $16.7K | $16.7K | $16.7K | $4.3K | · | · | |
| Accum. Depreciation | · | · | · | · | $16.7K | $15.4K | $11.7K | $9.5K | $4.6K | $2.0K | · | · | |
| Other Non-current Assets | $19.5K | $22.0K | $43.1K | $34.9K | $28.3K | $25.0K | $25.0K | $25.0K | $24.8K | $22.0K | · | · | |
| Total Assets | $94M | $46M | $98M | $153M | $223M | $118M | $117M | $10M | $3M | $3M | · | · | |
| Accounts Payable | $2M | $4M | $4M | $5M | $11M | $8M | $522.7K | $924.4K | $765.4K | $529.6K | · | · | |
| Accrued Liabilities | $5M | $6M | $9M | $7M | $4M | $4M | $824.9K | $1M | $659.5K | $394.6K | · | · | |
| Short-term Debt | · | · | · | · | · | · | $110.2K | $364.2K | $285.2K | $276.7K | · | · | |
| Current Liabilities | $6M | $10M | $12M | $12M | $15M | $13M | $1M | $3M | $6M | $1M | · | · | |
| Total Liabilities | $7M | $10M | $12M | $12M | $15M | $13M | $1M | $3M | $9M | $1M | · | · | |
| Total Debt | · | · | · | · | · | · | · | $364.2K | $285.2K | · | · | · | |
| Common Stock | $73.3K | $30.2K | $30.1K | $30.1K | $27.7K | $16.3K | $14.5K | $9.7K | $12.6K | $12.5K | · | · | |
| Paid-in Capital | $785M | $676M | $646M | $603M | $513M | $285M | $236M | $119M | $89M | $87M | · | · | |
| Retained Earnings | $-698M | $-641M | $-561M | $-462M | $-305M | $-179M | $-120M | $-112M | $-94M | $-85M | · | · | |
| Stockholders' Equity | $87M | $36M | $85M | $140M | $208M | $106M | $116M | $8M | $-6M | $1M | $7M | · | |
| Liabilities + Equity | $94M | $46M | $98M | $153M | $223M | $118M | $117M | $10M | $3M | $3M | · | · | |
| Shares Outstanding | 73,333,622 | 30,174,202 | 30,099,203 | 30,099,203 | 27,740,147 | 16,332,939 | 14,457,013 | 9,744,643 | 12,549,870 | 12,528,374 | · | · |
Flux de trésorerie 9
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $14M | $30M | $44M | $44M | $40M | $21M | $3M | $1M | $518.0K | $704.5K | · | · | |
| Operating Cash Flow | $-46M | $-52M | $-52M | $-104M | $-92M | $-28M | $-12M | $-10M | $-6M | $-6M | · | · | |
| CapEx | · | · | · | · | · | $182M | $85M | · | $12.4K | $49.7K | · | · | |
| Investing Cash Flow | $-48M | $52M | $50M | $20M | $-54M | $-34M | $-80M | · | $-12.4K | $-49.7K | · | · | |
| Stock Issued | $94M | · | · | $43M | $185M | $20M | · | $18M | · | · | · | · | |
| Net Stock Activity | $94M | · | · | $43M | $185M | $18M | · | $18M | · | · | · | · | |
| Financing Cash Flow | $94M | $-40.3K | $-98.5K | $45M | $188M | $28M | $126M | $17M | $7M | $-273.7K | · | · | |
| Net Change in Cash | · | · | · | · | · | · | · | $7M | $528.4K | $-7M | · | · | |
| Free Cash Flow | · | · | · | · | · | $-210M | · | · | $-6M | · | · | · |
Rentabilité 5
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | -2013.0% | -6063.3% | -10483.4% | -4348.0% | · | 1672.4% | 517.5% | · | · | · | |
| Net Margin | · | · | -1917.7% | -5905.2% | -10487.4% | -4249.2% | · | 2275.6% | 670.3% | · | · | · | |
| EBITDA Margin | · | · | -2013.0% | -6063.3% | -10483.4% | -4348.0% | · | 1672.4% | 517.5% | · | · | · | |
| ROA | -82.1% | -111.6% | -78.9% | -83.5% | -73.6% | -50.5% | · | -261.1% | -304.5% | · | · | · | |
| ROE | -112.0% | -192.4% | -106.2% | -102.4% | -89.5% | -52.2% | · | -428.3% | 228.9% | · | · | · |
Liquidité et Solvabilité 3
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 14.6 | 4.4 | 8.0 | 12.3 | 14.8 | 9.4 | · | 3.8 | 0.5 | · | · | · | |
| Quick Ratio | 14.5 | 4.4 | 7.9 | 11.9 | 11.1 | 9.3 | · | 3.5 | 0.4 | · | · | · | |
| Debt / Equity | · | · | · | · | · | · | · | 0.0 | -0.1 | · | · | · |
Efficacité 2
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | 0.0 | 0.0 | 0.0 | 0.0 | · | -0.1 | -0.5 | · | · | · | |
| Receivables Turnover | · | · | · | 10.4 | · | · | · | · | · | · | · | · |
Taux de croissance 2
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | 93.7% | 121.8% | -14.3% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | · | · | 54.4% | · | · | · | · | · | · | · | · | · |
Valorisation (TTM) 14
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $5.5K | $5.5K | $5.5K | $5.5K | $5.5K | $5.5K | · | $5.5K | $5.5K | $5.5K | $5.5K | $5.5K | |
| Net Income TTM | $-57M | $-80M | $-99M | $-157M | $-126M | $-59M | · | $-17M | $-9M | $-6M | · | · | |
| Market Cap | $354M | $16M | $125M | $105M | $625M | $524M | · | $289M | $51M | · | · | · | |
| Enterprise Value | · | · | · | · | · | · | · | $280M | $49M | · | · | · | |
| P/E | -3.3 | -0.2 | -1.3 | -0.7 | -3.1 | · | · | · | · | · | · | · | |
| P/S | 64260.0 | 2846.6 | 22607.2 | 19057.7 | 113386.3 | 95028.5 | · | 52471.1 | 9198.4 | · | · | · | |
| P/B | 4.1 | 0.4 | 1.5 | 0.7 | 3.0 | 5.0 | · | 38.0 | -9.2 | · | · | · | |
| P / Tangible Book | 4.1 | 0.4 | 1.5 | 0.7 | 3.0 | 5.0 | · | · | · | · | · | · | |
| P / Cash Flow | -7.7 | -0.3 | -2.4 | -1.0 | -6.8 | -18.8 | · | -27.6 | -8.4 | · | · | · | |
| P / FCF | · | · | · | · | · | -2.5 | · | · | -8.4 | · | · | · | |
| EV / EBITDA | · | · | · | · | · | · | · | -22.0 | -7.0 | · | · | · | |
| EV / FCF | · | · | · | · | · | · | · | · | -8.1 | · | · | · | |
| EV / Revenue | · | · | · | · | · | · | · | 50865.1 | 8843.9 | · | · | · | |
| Earnings Yield | -30.0% | -509.6% | -79.2% | -151.9% | -31.8% | · | · | · | · | · | · | · |
Compte de résultat 12
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $8M | $8M | $4M | $3M | $12M | $11M | $11M | $11M | $13M | $15M | $10M | $14M | $16M | $27M | $31M | $31M | |
| SG&A Expense | $11M | $12M | $6M | $7M | $6M | $8M | $12M | $8M | $10M | $12M | $12M | $12M | $12M | $12M | $8M | $15M | |
| Operating Expenses | $19M | $20M | $10M | $10M | $18M | $19M | $23M | $19M | $23M | $27M | $23M | $26M | $28M | $39M | $39M | $46M | |
| Operating Income | $-19M | $-20M | $-10M | $-10M | $-18M | $-19M | $-23M | $-19M | $-23M | $-27M | $-23M | $-26M | $-28M | $-39M | $-39M | $-46M | |
| Interest Income | $959.8K | $387.2K | $247.0K | $321.5K | $440.3K | $654.6K | $856.5K | $963.0K | $1M | $1M | $1M | $1M | $1M | · | · | · | |
| Other Non-op | $409.8K | $465.4K | $235.8K | $354.9K | $659.0K | $418.4K | $1M | $1M | $1M | $2M | $690.6K | $723.8K | $2M | $758.1K | $-681.5K | $6M | |
| Net Income | $-19M | $-20M | $-10M | $-10M | $-18M | $-19M | $-22M | $-18M | $-22M | $-25M | $-22M | $-25M | $-26M | $-38M | $-39M | $-40M | |
| EPS (Basic) | $-0.22 | $-0.27 | $-0.30 | $-0.30 | $-0.58 | $-0.62 | $-0.72 | $-0.59 | $-0.72 | $-0.84 | $-0.73 | $-0.84 | $-0.87 | $-1.26 | $-1.31 | $-1.33 | |
| EPS (Diluted) | $-0.22 | $-0.27 | $-0.30 | $-0.30 | $-0.58 | $-0.62 | $-0.72 | $-0.59 | $-0.72 | $-0.84 | $-0.73 | $-0.84 | $-0.87 | $-1.26 | $-1.31 | $-1.33 | |
| Shares (Basic) | 86,596,873 | -57,312,440 | 33,191,622 | 33,191,622 | 30,408,890 | -60,316,823 | 30,174,202 | 30,174,202 | 30,132,170 | -60,198,406 | 30,099,203 | 30,099,203 | 30,099,203 | 158,466 | 30,063,735 | 29,935,895 | |
| Shares (Diluted) | 86,596,873 | -57,312,440 | 33,191,622 | 33,191,622 | 30,408,890 | -60,316,823 | 30,174,202 | 30,174,202 | 30,132,170 | -60,198,406 | 30,099,203 | 30,099,203 | 30,099,203 | -58,763,567 | 30,063,735 | 29,935,895 | |
| EBITDA | $-19M | · | $-10M | $-10M | $-18M | · | $-23M | $-19M | $-23M | · | $-23M | $-26M | $-28M | · | $-39M | $-46M |
Bilan 18
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $10M | $3M | $1M | $1M | $1M | $4M | $1M | $2M | $1M | $4M | $7M | $14M | $29M | $5M | $43M | $37M | |
| Short-term Investments | $224M | $90M | $13M | $19M | $26M | $41M | $53M | $68M | $82M | $92M | $100M | $104M | $104M | $143M | $142M | $175M | |
| Receivables | · | · | · | · | · | · | · | · | · | · | · | · | · | $512.4K | · | · | |
| Prepaid Expense | $1M | $977.7K | $967.7K | $474.6K | $596.4K | $886.5K | $2M | $537.5K | $752.3K | $1M | $3M | $3M | $3M | $4M | $3M | $3M | |
| Other Current Assets | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $256.2K | |
| Current Assets | $235M | $94M | $15M | $21M | $28M | $46M | $56M | $71M | $84M | $98M | $109M | $122M | $136M | $153M | $187M | $216M | |
| Other Non-current Assets | $19.5K | $19.5K | $22.0K | $22.0K | $22.0K | $22.0K | $22.0K | $53.6K | $43.1K | $43.1K | $47.7K | $34.6K | $34.9K | $34.9K | $16.1K | $35.2K | |
| Total Assets | $235M | $94M | $15M | $21M | $28M | $46M | $56M | $71M | $84M | $98M | $109M | $122M | $136M | $153M | $187M | $216M | |
| Accounts Payable | $6M | $2M | $1M | $1M | $1M | $4M | $2M | $4M | $5M | $4M | $3M | $5M | $4M | $5M | $10M | $8M | |
| Accrued Liabilities | $7M | $5M | $4M | $4M | $4M | $6M | $6M | $5M | $7M | $9M | $6M | $6M | $6M | $7M | $10M | $11M | |
| Current Liabilities | $13M | $6M | $5M | $5M | $5M | $10M | $8M | $10M | $12M | $12M | $8M | $11M | $10M | $12M | $21M | $19M | |
| Total Liabilities | $17M | $7M | $5M | $5M | $5M | $10M | $8M | · | $12M | $12M | · | · | $10M | $12M | · | · | |
| Common Stock | $104.9K | $73.3K | $33.2K | $33.2K | $33.2K | $30.2K | $30.2K | $30.2K | $30.2K | $30.1K | $30.1K | $30.1K | $30.1K | $30.1K | $28.6K | $30.0K | |
| Paid-in Capital | $936M | $785M | $688M | $684M | $681M | $676M | $670M | $662M | $655M | $646M | $636M | $625M | $614M | $603M | $590M | $582M | |
| Retained Earnings | $-717M | $-698M | $-678M | $-668M | $-658M | $-641M | $-622M | $-600M | $-583M | $-561M | $-536M | $-514M | $-488M | $-462M | $-424M | $-385M | |
| Stockholders' Equity | $219M | $87M | $9M | $16M | $22M | $36M | $48M | $61M | $72M | $85M | $101M | $111M | $125M | $140M | $166M | $197M | |
| Liabilities + Equity | $235M | $94M | $15M | $21M | $28M | $46M | $56M | $71M | $84M | $98M | $109M | $122M | $136M | $153M | $187M | $216M | |
| Shares Outstanding | 104,890,223 | 73,333,622 | 33,191,622 | 33,191,622 | 33,191,622 | 30,174,202 | 30,174,202 | 30,174,202 | 30,174,202 | 30,099,203 | 30,099,203 | 30,099,203 | 30,099,203 | 30,099,203 | 28,641,991 | 30,024,594 |
Flux de trésorerie 8
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $956.2K | $2M | $4M | $3M | $4M | $7M | $8M | $7M | $8M | $10M | $11M | $11M | $11M | $12M | $8M | $12M | |
| Operating Cash Flow | $-15M | $-15M | $-7M | $-6M | $-18M | $-9M | $-17M | $-13M | $-13M | $-10M | $-12M | $-13M | $-17M | $-36M | $-27M | $-22M | |
| Investing Cash Flow | $-135M | $-77M | $7M | $7M | $15M | $11M | $16M | $14M | $10M | $8M | $4M | $-1M | $40M | $-2M | $32M | $-140.5K | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $13M | |
| Stock Repurchased | $3M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | $-3M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $157M | $94M | $0 | · | · | $-172.5K | $-89.6K | $0 | $221.7K | · | · | · | · | $409.9K | $569.1K | $14M | |
| Net Change in Cash | · | · | · | · | · | · | · | · | · | · | · | $-14M | $23M | · | · | $-8M |
Rentabilité 5
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | · | · | · | -1717.3% | -1909.0% | -2331.3% | · | -4680.6% | -11750.1% | |
| Net Margin | · | · | · | · | · | · | · | · | · | · | -1665.0% | -1855.9% | -2179.6% | · | -4762.9% | -10310.2% | |
| EBITDA Margin | · | · | · | · | · | · | · | · | · | · | -1717.3% | -1909.0% | -2331.3% | · | -4680.6% | -11750.1% | |
| ROA | -14.5% | · | -28.6% | -21.4% | -31.3% | · | -26.4% | -18.4% | -19.9% | · | -14.8% | -15.0% | -14.6% | · | -28.3% | -24.5% | |
| ROE | -15.8% | · | -35.4% | -25.5% | -37.2% | · | -29.3% | -20.6% | -22.1% | · | -16.5% | -16.4% | -15.7% | · | -33.0% | -27.2% |
Liquidité et Solvabilité 2
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 18.3 | · | 2.9 | 4.1 | 5.3 | · | 6.9 | 7.4 | 6.8 | · | 13.0 | 11.4 | 13.4 | · | 9.0 | 11.4 | |
| Quick Ratio | 18.1 | · | 2.7 | 4.0 | 5.2 | · | 6.7 | 7.4 | 6.8 | · | 12.6 | 11.1 | 13.1 | · | 8.9 | 11.2 |
Efficacité 1
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 |
Valorisation (TTM) 9
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $5.5K | · | $5.5K | $5.5K | $5.5K | · | $5.5K | $5.5K | $5.5K | · | $5.5K | $5.5K | $5.5K | · | $5.5K | $5.5K | |
| Net Income TTM | $-57M | · | $-59M | $-67M | $-79M | · | $-83M | $-87M | $-95M | · | $-113M | $-131M | $-145M | · | $-162M | $-149M | |
| Market Cap | $730M | · | $67M | $20M | $9M | · | $98M | $91M | $140M | · | $90M | $74M | $68M | · | $1.06B | $570M | |
| P/E | -5.0 | · | -1.1 | -0.3 | -0.1 | · | -1.2 | -1.0 | -1.5 | · | -0.8 | -0.6 | · | · | · | · | |
| P/S | 132444.8 | · | 12103.6 | 3613.0 | 1625.9 | · | 17736.6 | 16422.8 | 25455.4 | · | 16382.0 | 13433.2 | 12341.1 | · | 192366.9 | 103441.0 | |
| P/B | 3.3 | · | 7.0 | 1.2 | 0.4 | · | 2.1 | 1.5 | 1.9 | · | 0.9 | 0.7 | 0.5 | · | 6.4 | 2.9 | |
| P / Tangible Book | 3.3 | · | 7.0 | 1.2 | 0.4 | · | 2.1 | 1.5 | 1.9 | · | 0.9 | 0.7 | 0.5 | · | 6.4 | 2.9 | |
| P / Cash Flow | -48.5 | · | · | · | -0.5 | · | · | · | -10.8 | · | · | · | -4.1 | · | · | · | |
| Earnings Yield | -20.1% | · | -94.5% | -365.0% | -966.7% | · | -85.2% | -96.0% | -68.0% | · | -125.0% | -176.8% | · | · | · | · |
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
Compte de résultat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Marge d'exploitation % | — | — | -2013.0% | -6063.3% | -10483.4% |
| Résultat net | $-57M | $-80M | $-99M | $-157M | $-126M |
| BPA dilué | $-1.45 | $-2.65 | $-3.28 | $-5.30 | $-7.16 |
Bilan
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ratio de liquidité | 14.6 | 4.4 | 8.0 | 12.3 | 14.8 |
| Ratio de liquidité réduite | 14.5 | 4.4 | 7.9 | 11.9 | 11.1 |
Dernières actualités Actualités récentes mentionnant cette entreprise
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
📊
Choisissez les indicateurs qui vous importent — cliquez sur le ➕ à côté de n'importe quelle ligne dans Fondamentaux Complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.